EGFR and hepatocellular carcinoma: In contrast to its oncogenic roles, in hepatocellular carcinoma (HCC), MAOA was linked to better patient prognoses and was found to suppress metastasis by inhibiting the adrenergic system and its transactivation of epidermal growth factor receptor (EGFR) signaling [14].